Piramal Pharma Limited at its board meeting held on May 10, 2024, recommended a final dividend of INR 0.11 per Equity Share of INR 10 each for the financial year ended 31 March 2024, which will be paid /dispatched after the 4th Annual General Meeting, subject to the approval of shareholders of the Company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
149.7 INR | +1.39% | +1.84% | +7.81% |
14/05 | Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy | MT |
13/05 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.81% | 2.35B | |
+38.51% | 727B | |
+32.13% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.81% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- PPLPHARMA Stock
- News Piramal Pharma Limited
- Piramal Pharma Limited Recommends Final Dividend for the Financial Year Ended 31 March 2024